SOUTH JORDAN, Utah, Sept. 6, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate in three investor conferences in September.
On Wednesday, September 12 th, at 8:00 a.m. ET, Merit's Chief Financial Officer Kent W. Stanger will present at CL King's Best Ideas Conference at the Omni Berkshire Place Hotel in New York City.
On Tuesday, September 18 th, Stanger will participate in the Lazard Capital Markets 1x1 Corporate Access Day at the Westin Boston Waterfront Hotel.On Wednesday, September 19 th, at approximately 3:30 p.m. ET, Stanger will present at the UBS Global Life Sciences Conference at the Grand Hyatt in New York City. Stanger will also participate in one-on-one meetings throughout these conferences. ABOUT MERIT Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately 165 individuals. Merit employs approximately 2,600 people worldwide with facilities in Salt Lake City and South Jordan, Utah; Angleton, Texas; Richmond, Virginia; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Copenhagen, Denmark; and Rockland, Massachusetts. The Merit Medical Systems, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3282
CONTACT: Anne-Marie Wright Vice President, Corporate Communications Phone: 801) 208-4167 e-mail: email@example.com Fax: (801) 253-1688
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts